Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACH: Efaproxiral + WBRT for Brain Metastases
NCT00005887Phase 3Completed
- Sponsor
- Spectrum Pharmaceuticals, Inc.
- Start
- Feb 2000
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of efaproxiral in brain metastases, sponsored by Spectrum Pharmaceuticals, Inc.. Started Feb 2000; status: completed.
02
Drugs
efaproxiral
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00005887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005887.